Abstract Purpose: To sequentially synthesize piperidine-4-carboxylic acid ethyl ester-appended 1,3,4-oxadiazole hybrids and to evaluate them as anticancer agents.
INTRODUCTION
Heterocyclic compounds have gained great interest by chemists in the quest for new significant therapeutic and pharmacological agents [1] . Nitrogen and oxygen based azoles are well known and identified as bioactive agents in field of pharmacy. Azoles are having great extent of pharmacological applications because of heteroatoms providing active sites for inter action. Oxadizole and triazole are members of the azole family having wide range of biological applications.1,3,4-oxadiazole derivatives are reported as strong antibacterial [2] , antidepressant [3] , anti-proliferate [4] , anti-HIV [5] , anti-inflammatory [6] , anti-mitotic [7] , hypoglycemic [8] , anti-cancer [9] , herbicidal [10] , muscle relaxant [11] , anticonvulsant [12] , insecticidal [13] , anti-fungal [14] and plant growth regulator agents [15] . The current work is the continuity of our efforts to add some new compounds in the field of synthetic chemistry having various modifications in the structural frame work. In the same year we have reported acetamides derivatives based on azinane bearing 1,3,4-oxadiazole as active anti-bacterial agents [16] . The current study was to evaluate the effect of propanamide bearing three carbons in place of acetamides bearing two carbons. The synthesis of targeted compounds 6a-l is significant, as it has different heterocyclic systems submerged in one unit in order to enhance their biological applications, in the evaluation of anticancer activity.
EXPERIMENTAL General
The progress and completion of reactions was checked by TLC on pre-coated silica gel plates by UV 254 lamp along with ethyl acetate and nhexane (different polarity solvent system). Griffin and George apparatus was employed to calculate the melting points of compounds 6a-l [16] . The presence of various functional groups in compounds 6a-l were identified by IR technique using Jasco-320-A spectrophotometer. With the help of Bruker spectrometers, 1 H-NMR (at 600 MHz in MeOD) and 13 C-NMR (at 400 MHz in MeOD) spectra were recorded. Mass spectral analysis was attained by JMS-HX-110 spectrometer.
Synthesis of ethyl 1-[(4-methylphenyl)sulfonyl]-4-piperidinecarboxylate (1)
Ethyl 4-piperidinecarboxylate (b: 0.04 mol) was added into round bottom flask having 20 ml distilled water. The mixture was agitated for 10 minutes followed by the addition of 4-methylbenzenesulfonylchloride (a: 0.04 mol) gradually. A volume of 5 % Na 2 CO 3 solution was used to maintain the pH of solution up to 9-10 until the completion of reaction. As the reaction completed, the product in the form of precipitates was attained by addition of distilled water.
Synthesis of ethyl 1-[(4-methylphenyl)sulfonyl]-4-piperidine carbohydrazide (2)
Compound 1 (0.019 mol) was dissolved in 20 ml of methanol and refluxed with hydrazine hydrate for 4 hours. TLC was performed throughout the reaction to monitor the reaction completion. At the completion of reaction, the mixture was cooled at room temperature. The precipitates of target compound 2 were acquired by the water addition followed by the filtration and washing.
Synthesis of 5-{1-[(4-methylphenyl)sulfonyl]-4-piperidinyl}-1,3,4-oxadiazole-2-thiol (3)
Compound 2 (0.02 mol) and KOH (0.02 mol) were dissolved in methanol and refluxed with carbon disulphide (0.02mol) for 5 hours. TLC was performed after every to check the progress of reaction. At the completion of reaction, distt. H 2 O and dil. HCl (to adjust pH to 4-5) were used to acquire the precipitates of titled product. Precipitates were filtered, washed and dried at room temperature.
General procedure for synthesis of N-aryl-2-bromopropanamides (5a-l)
A mixture of 2-bromopropionyl bromide and aryl amines (4a-l; 0.02 mol) was stirred for 1 hour in aqueous medium by following reported method [17] . The pH was adjusted to 9-10 by addition of 10% Na 2 CO 3 solution. The reaction mixture was stirred vigorously to attain the precipitates. The obtained product was filtered and dried. Compound 4 (0.006 mol) was stirred with lithium hydride in the presence of DMF for 30 minutes N-substituted propanamides (5a-l) were subsequently added. The reaction mixture stirred for 4 hours at the room temperature. Reaction progress was monitored by TLC. Following the addition of cold distilled water, the target compounds (6a-l) were obtained in the form of precipitates that were filtered, washed and dried.
Anticancer activity assay
The anticancer activity (in vitro) was evaluated using the reported method for MTT assay [18] . For the anticancer potential, the change in absorbance of mixture and cell line before and after incubation was determined. 
Statistical analysis

RESULTS
The methodology of all N-substituted propanamide derivatives of 1,3,4-oxadiazole have been summarized in scheme-1. The MTT assay is at best used for initial screening and the activities were from moderate to high.
N-(2,3-dimethylphenyl)-2-[[5-[1-[(4-methyl phenyl)sulfonyl]-4-piperidinyl]-1,3,4-oxadiazol-2-yl]thio]-propanamide (6a)
Pink amorphous solid; Yield: 80 %; M. 
N-(2-ethylphenyl)-2-[[5-[1-[(4-methyl phenyl)sulfonyl]-4-piperidinyl]-1,3,4-oxadiazol-2-yl]thio]-propanamide (6j)
Anticancer activity
The results are given as % inhibition and IC 50 ± SD in Table 2 .
DISCUSSION
Compound 6c, light brown amorphous solid, having melting point 150-152 °C with 85 % yield was selected randomly for single molecule discussion to explain the structural elucidation of synthesized compound. Deduction of molecular formula and molecular mass was done through EIMS spectrum and molecular ion peak at m/z = 514 respectively.
The presence of the main functional groups was confirmed by considering the absorption peaks presented by IR spectrum. Existence of N-H was verified by the peak at 3448cm The detailed spectral studies made us able to deduce the name of discussed compound 6c as N- (2,5- All the compounds were screened for their anticancer activity and were found to possess moderate to high anticancer potential. Compounds 6h, 6j and 6e having high anticancer potential, 74.19, 86.53 and 89.50 % measured in terms of % inhibition, compared to doxorubicin (89.19 %) used as reference. The ascending order of anticancer activity of compounds 6h, 6j and 6e was due to the different substituted alkyl groups at aromatic ring of propanamides. Compound 6h, 6j both have aromatic ring of propanmides substituted with bulky ethyl groups which might be responsible for their lower anticancer activity when compared to compound 6e having substitution of methyl group at ortho position of aromatic ring [19, 20] .
The substituted ethyl groups showed hydrophobic characteristics and reduced the interaction between substrate and compounds 6h, 6j while this character was less effective and less dominant for compound 6e. Compound 6e with impressive good inhibition requires further studies for possible development and addition to existing anticancer agents in the pharmaceutical industry. MTT assay is an initial screening and other assays for in vitro and in vivo will be required to support the anticancer potential. Figure-1 has explained the structural features and anticancer potential of the compounds 6e, 6h and 6j. 
CONCLUSION
All the compounds have been synthesized with good yield and their structures corroborated using spectroscopic techniques and mass spectroscopy). The compounds have moderate to high anticancer impact. Compounds 6h, 6j and 6e have good potentials as anticancer agents. However among these three compounds, compound 6e was outstanding and possess even better anticancer potential when compared to the Doxorubicin as standard. Therefore compound 6e should be further investigated.
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